Nevro Corp (NYSE: NVRO) on Tuesday, plunged -1.52% from the previous trading day, before settling in for the closing price of $5.91. Within the past 52 weeks, NVRO’s price has moved between $4.38 and $22.64.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 2.01% annually for the last half of the decade. The company achieved an average annual earnings per share of -8.87%. With a float of $35.20 million, this company’s outstanding shares have now reached $36.36 million.
In an organization with 1215 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.58%, operating margin of -22.03%, and the pretax margin is -19.54%.
Nevro Corp (NVRO) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Nevro Corp is 5.59%, while institutional ownership is 106.08%.
Nevro Corp (NVRO) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.65 earnings per share (EPS) for the period topping the consensus outlook (set at -0.77) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.69 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.87% per share during the next fiscal year.
Nevro Corp (NYSE: NVRO) Trading Performance Indicators
Nevro Corp (NVRO) is currently performing well based on its current performance indicators. A quick ratio of 3.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Nevro Corp (NVRO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.55 million. That was inferior than the volume of 0.58 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 66.60%. Additionally, its Average True Range was 0.65.
During the past 100 days, Nevro Corp’s (NVRO) raw stochastic average was set at 15.20%, which indicates a significant decrease from 72.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 106.86% in the past 14 days, which was lower than the 117.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.95, while its 200-day Moving Average is $13.31. However, in the short run, Nevro Corp’s stock first resistance to watch stands at $6.08. Second resistance stands at $6.35. The third major resistance level sits at $6.55. If the price goes on to break the first support level at $5.61, it is likely to go to the next support level at $5.41. Assuming the price breaks the second support level, the third support level stands at $5.14.
Nevro Corp (NYSE: NVRO) Key Stats
Market capitalization of the company is 216.97 million based on 36,729K outstanding shares. Right now, sales total 425,170 K and income totals -92,210 K. The company made 104,160 K in profit during its latest quarter, and -19,580 K in sales during its previous quarter.
